Intersectionality between gene and gender:biopolitics and the control of risky female bodies by Cheded, Mohammed & Hopkinson, Gillian
Intersectionality between gene and gender: biopolitics and the control of 
risky female bodies 
Mohammed Cheded* and Gillian Hopkinson, De Montfort University and Lancaster 
University 
*Corresponding author. E-mail: mohammed.cheded@dmu.ac.uk 
Extended abstract prepared for the 43th annual conference of the Macromarketing Society, 
09-12th July 2018, Leipzig, Germany 
  
The aim of this paper is to explore the role of biological identity factors in reinforcing 
oppression experienced in the marketplace, and assess what a study of the intersectionality 
between gender and genetic identity has to offer to the macromarketing scholarship. To do 
so, we discuss the concept of geneticism drawing on the sociology of health and illness, before 
connecting it to other ‘isms’ of oppression. Thus, we attend to the cultural, social and 
historical contexts of the construction of a genetic identity, which leads to consider the 
intimate connection between gene and race1 (Siddhartha, 2016). Then an illustrative case is 
provided, which relates gene to gender; namely the BRCA gene mutation and breast and 
ovarian cancers. Within this case, we focus on the rise of the market of prevention in the 
context of genetic propensity to breast and ovarian cancers, partly due to the possibility of 
reconstruction of the heteronormative female body through the breast reconstruction 
surgery. Our analysis illuminates the experiences of oppression in the marketplace resulting 
from geneticism, but also the politics of access to genetic knowledge. Finally, the case is 
connected back to the discussion on gender, intersectionality and macromarketing. 
To illustrate the intersectionality between gender and genetic identity, this paper focuses on 
the market for preventive solutions for breast and ovarian cancers. We use a multitude of 
                                                          
1 We will explore, in the full paper, the historic relationship between eugenics and genetics, and how genetics 
discourse has sought to carve out a distinct and untainted area. American eugenics was embedded in an openly 
racist ideology of white supremacy (Allen, 1983), and eugenics’ programmes were focused on controlling and 
reducing the breeding of the unfit/genetically defective (or what was defined as such). It is therefore not 
surprising to see the efforts of genetics science to demarcate its commitments from those of eugenics 
throughout history. Probably the most notable narrative is the depiction of genetics knowledge as a platform 
for individual choice. At the core of the rhetoric of individual choice is the freedom to choose – therefore 
contrasting it with the coercive discourse of eugenics. However, and as we will discuss in depth in our full paper, 
these distinctions largely depend on the social, historical and cultural contexts where they are traced. Indeed, 
genetics reproduces and reinforces several eugenics ideologies, as has been debated in the sociology of health 
and illness literature. This is particularly relevant when considering how it shapes the causal attributions 
between the individual, the disease, and the state (Kerr, 2004, Tutton, 2012, Rose, 2007). 
public online sources such as newspapers (including Angelina Jolie’s letter to The New York 
Times, ‘my medical choice’ (Jolie, 2013), which has sparked an enormous interest amongst 
various market actors), activist’ websites, and online support groups. We emphasise 
prevention in the context of genetic propensity for these illnesses. We focus on a specific set 
of genes, the BRCA genes (BRCA1 and BRCA2). The inheritance of a BRCA mutation is 
associated with an increased risk of developing breast and ovarian cancers over a lifetime. 
Our objective is to examine the performativity of knowledge claims about the gene, the body 
and the disease affecting the newly redefined at-risk entities (Butler, 1993; Lupton, 2012); as 
well as the new consumption practices targeted at these entities, centred on risk prevention 
and the reconstruction of the heteronormative body (Klawiter, 2008; King, 2004). Thus, we 
highlight genetic determinism or ‘geneticism’ (Lippmann, 1991; Nelkin and Lindee, 1995) as a 
possible medium of oppression. Genetic determinism or ‘geneticism’ comes into play when a 
disease is talked about predominantly in terms of genetic causality. Within geneticism, the 
gene is understood as a strong determinant of the essence of personal identity2, as it provides 
a ‘scientific’ explanation for the occurrence of degeneracy.  The mapping of the genome 
defines and delineates the normal human body through the othering of diseases and other 
imperfections. Thus, it constructs the human body as a flawed version of a supposedly 
existent ideal, perfect code (Van Dijk, 1998). We aim to highlight, within this paper, the 
interplay of geneticism and other means of oppression, such as sexism and heterosexism, in 
constituting women bodies as sites of control.  In keeping with a macromarketing perspective, 
we look across a range of market actors with a particular emphasis upon the positioning of 
women as consumers of prevention in the era of genetic citizenship (Kerr, 2004).  
The empirical work brings to the fore the transformation of the discourse of survivorship to 
previvorship through the movement of the locus of action from ill to pre-ill bodies. This 
discourse has a pivotal role in mobilising action, both from the affected women and the 
various market actors. Locating our research within a feminist postructuralist framework, we 
discuss the various narratives and symbols of survivorship and previvorship, and their co-
constitutive relationship with the marketization of breast cancer movement. This the 
redefinition of its prevention, and the shaping of a market around preventive solutions. As we 
                                                          
2 The way genetics determines the essence of personal identity is different from eugenics, as it marks a shift 
from the ‘gene as controller’ to the ‘genome as book of life’ or ‘master code’ (Van Dijk, 1998). 
trace these discursive movements, we demonstrate the involvement of two major 
approaches to breast cancer activism. On the one hand, the mainstream activism focuses 
essentially on fundraising, and has worked towards the destigmatisation of the disease, 
research funding, screening and education. The mobilisation around the pink ribbon is a great 
example of such activism. Mainstream activism contributed strongly into shaping the 
treatments, the screening methods, as well as the number of spaces for support available for 
patients. However, this type of activism does not necessarily challenge the established 
approaches of its areas of action (research, screening and education), as has been pointed 
out by feminist critiques (Klawiter, 2008; King, 2004). On the contrary, it reiterates and 
reinforces the geneticism discourse. On the other hand, feminist activism has been geared 
towards political action. The main purpose of these activists is destabilising the dominant 
methods of understanding and acting on breast cancer. Some of the major topics that it 
addresses are environmental contaminants as a cause for cancer (as opposed to a sole focus 
on genetic determinants), the blurring of the lines between prevention and early detection, 
as well as issues of access to the marginalised such as poor people, ethnic minorities, disabled, 
and LGBT women.  
These two movements do not diverge only through their commitments but also through the 
framing of the female body. Whilst the mainstream breast cancer movement promoted 
unscarred, heterofeminine albeit cancerised bodies, feminist activists championed making 
spaces available for the expression of “alternative images, alternative discourses, and 
alternative ways of embodying breast cancer” (Klawiter, 2008, p. 169). We uncover similar 
practices within the pre-ill female body, carrier of a faulty gene – or BRCA positive. Within this 
context, taking control of the occurrence of breast cancer through preventive surgery, is 
interwoven with the possibility of re-enactement of the heteronormative body through 
reconstructive surgery3. This latter approach provides previvorship a ‘restitution narrative’ 
(Frank, 1995), where the ‘loss’ of womanhood through the removal of breasts can be fixed 
                                                          
3 By re-enactment of heteronormative body through reconstructive surgery, we do not imply that female 
sexuality interferes with their access to treatment (or at least, we do not explore this aspect), nor that there is 
a typical physical representation of LGBTI female bodies. Instead, we refer to the heteronormative 
conceptualisations of the female body, and the making of the ‘possibility’ of reconstruction as a necessity, and 
an integral part of the preventive procedures. This in turn marginalises the scarred, one breasted and un-
breasted female bodies following preventive surgery – whether this visual representation is due to issues of 
access (financial, geographical, legal, etc.), or to individual choice. 
through various technologies of the body. These technologies of the body (Foucault, 2004) 
such as breast reconstruction, prostheses, wigs and a careful choice of clothing, transform 
breast cancer previvors’ bodies, so they can mirror the image of healthy ones – an ideal that 
is encouraged within the previvorship discourse. We trace the spatio-temporal movement of 
the ‘restitution narrative’, as it travels from cancerous to pre-cancerous bodies, from the ill 
to the pre-ill, aided by the geneticisation discourse. 
 
In focusing on geneticisim, we provide an understanding of an additional layer of 
intersectional identities. While destabilising the control of the body by conceptualising a part 
of it as defectous, genetics discourse fosters simultaneously a sense of control, by making 
additional options available to reduce uncertainty, and re-enacts what is considered as a 
‘normal’ female body through a heteronormative lens. However, if we consider the need to 
organise and control something frightening and chaotic as stemming from its initial 
representation as such, then the centricity of the notion of control of degeneracy to genetics 
becomes problematic. By shedding the light on these considerations, we hope to extend the 
literature on women bodies as sites of control within the macromarketing and critical 
marketing literature (Gurrieri et al, 2013; Maclaran et al.,2009), by highlighting the role of 
geneticism in pushing the neoliberal body project under the banner of individual choice. 
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